Clinical Trial Update: Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis [EARLY_Phase 1]

View source ↗

Summary

Ongoing Phase 1 trial investigating a novel antisense oligonucleotide eye drop for treating antibiotic-resistant bacterial keratitis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Keratitis

Drugs mentioned

• Antisense Oligonucleotide Eye Drops

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Bacterial Keratitis, Antibiotic-resistant Bacteria | EARLY_Phase 1 | Status: RECRUITING